Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 6/20 | 0.51 |
| ▸ | AVPR1A | P37288 | 6/20 | 0.51 |
| ▸ | OXTR | P30559 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8561629 | 0.89 | AVPR2 (0.52) | AVPR2AVPR1AOXTRNPC1HPGD | |
| SCHEMBL8561249 | 0.84 | AVPR2 (0.50) | AVPR2AVPR1AOXTR | |
| SCHEMBL7332334 | 0.83 | AVPR1A (0.66) | AVPR2AVPR1A | |
| SCHEMBL8564026 | 0.80 | AVPR1A (0.43) | AVPR2AVPR1ANPC1HPGDRAB9A | |
| SCHEMBL8558249 | 0.80 | NPC1 (0.45) | AVPR2AVPR1ANPC1HPGDRAB9A | |
| SCHEMBL8561685 | 0.80 | AVPR1A (0.44) | AVPR2AVPR1ANPC1HPGDRAB9A | |
| SCHEMBL8559548 | 0.80 | POLB (0.51) | AVPR2AVPR1AHPGD | |
| SCHEMBL8561048 | 0.79 | AVPR2 (0.48) | AVPR2AVPR1A | |
| SCHEMBL8562708 | 0.78 | AVPR1A (0.50) | AVPR2AVPR1ANPC1HPGDRAB9A | |
| SCHEMBL8563827 | 0.78 | ALDH1A1 (0.47) | AVPR2AVPR1ANPC1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0640592-B1 | N-acylated tricyclic azaheterorings useful as vasopressin antagonists | AMERICAN CYANAMID CO (US) | 1998-12-30 | — | — | EP | disclosed |